|国家科技期刊平台
首页|期刊导航|现代检验医学杂志|2型糖尿病患者血清miR-103a和miR-497水平表达与微血管病变发生的相关性研究

2型糖尿病患者血清miR-103a和miR-497水平表达与微血管病变发生的相关性研究OACSTPCD

Study on Correlation between Serum miR-103a,miR-497 Expression and Micro Vascular Disease in Patients with Type 2 Diabetes Mellitus

中文摘要英文摘要

目的 探究2型糖尿病(type 2 diabetes mellitus,T2DM)患者血清微小RNA-103a(miR-103a),微小RNA-497(miR-497)水平表达与微血管病变(micro vascular disease,MVD)发生的相关性.方法 选取2022年5月~2023年4月在唐山市协和医院确诊的T2DM患者作为研究组(n=113),根据是否并发MVD分为2型糖尿病微血管病变(type 2 diabetes microangiopathy,DMAP)组(n=51)和 T2DM(n=62)组,选取同期体检健康人员作为对照组(n=105).收集患者临床资料,实时荧光聚合酶链反应(real-time fluorescence polymerase chain reaction,qRT-PCR)检测血清miR-103a和miR-497水平,采用Logistic回归分析T2DM并发MVD的影响因素,绘制受试者工作特征(receiver operating characteristic,ROC)曲线分析血清miR-103a和miR-497水平对T2DM并发MVD的诊断价值.结果 研究组血清miR-103a(0.62±0.13)和 miR-497(0.79±0.14)水平显著低于对照组(0.96±0.16,1.03±0.18),差异具有统计学意义(t=17.273,11.031,均 P<0.05).DMAP 组血清 miR-103a(0.53±0.08)和 miR-497(0.69±0.10)水平显著低于 T2DM 组(0.69±0.10,0.87±0.13),差异具有统计学意义(t=9.247,8.108,均 P<0.05).DMAP 组病程≥ 8 年、并发高血脂患者比例、空腹血糖(FBG)、总胆固醇(TC)、血肌酐(Scr)和尿素氮(BUN)水平显著高于T2DM组,差异具有统计学意义(t/x2=8.294,15.342,-2.855,-5.659,-8.951,-3.880,均 P<0.05).血清 miR-103a,miR-497及二者联合诊断T2DM并发MVD的曲线下面积(area under curve,AUC)分别为0.899,0.897和0.970,二者联合诊断效果优于各自单独诊断(Z=2.268,2.267,均P<0.05).Logistic多因素回归分析结果显示FBG(OR=1.879,95%CI:1.262~2.797),TC(OR=2.141,95%CI:1.348~3.400)和 Scr(OR=3.417,95%CI:1.569~7.440)是 T2DM并发 MVD 的独立风险因素(均 P<0.05),miR-103a(OR=0.784,95%CI:0.648~0.948)和 miR-497(OR=0.839,95%CI:0.750~0.938)是T2DM并发MVD的保护因素(均P<0.05).结论 T2DM并发MVD患者血清miR-103a和miR-497低表达,其可能成为诊断T2DM并发MVD的潜在标志物.

Objective To explore the correlation between the expression of serum microRNA(miR)-103a and microRNA(miR)-497 and micro vascular disease(MVD)in patients with type 2 diabetes mellitus(T2DM).Methods Patients diagnosed with T2DM in Tangshan Union Medical College Hospital from May 2022 to April 2023 were selected as the study group(n=113),which were divided into type 2 diabetes microangiopathy(DMAP)group(n=51)and T2DM group(n=62)according to whether MVD was complicated.Healthy subjects in the same period were selected as control group(n=105).Clinical data were collected,and real-time fluorescence polymerase chain reaction(qRT-PCR)was applied to detect serum levels of miR-103a and miR-497.Logistic regression was applied to analyze the influencing factors of T2DM complicated with MVD.Receiver operating characteristic(ROC)curve was plotted to analyze the diagnostic value of serum miR-103a and miR-497 levels in T2DM complicated with MVD.Results The serum levels of miR-103a(0.62±0.13)and miR-497(0.79±0.14)in the study group were lower than those in the control group(0.96±0.16,1.03±0.18),with significant differences(t=17.273,11.031,all P<0.05).The serum levels of miR-103a(0.53±0.08)and miR-497(0.69±0.10)in the DMAP group were lower than those in the T2DM group(0.69±0.10,0.87±0.13),with significant differences(t=9.247,8.108,all P<0.05).The proportions of patients with a disease course of ≥ 8 years and concomitant hyperlipidemia,and the levels of FBG,TC,Scr and BUN in the DMAP group were higher than in the T2DM group,with significant differences(t/x2=8.294,15.342,-2.855,-5.659,-8.951,-3.880,all P<0.05).The area under curve(AUC)of serum miR-103a,miR-497 and their combination in the diagnosis of T2DM with MVD were 0.899,0.897 and 0.970,respectively.The combined diagnosis effect was better than that of individual diagnosis(Z=2.268,2.267,all P<0.05).The results of logistic regression analysis showed that FBG(OR=1.879,95%CI:1.262~2.797),TC(OR=2.141,95%CI:1.348~3.400),and Scr(OR=3.417,95%CI:1.569~7.440)were independent risk factors for T2DM with MVD(all P<0.05),while miR-103a(OR=0.784,95%CI:0.648~0.948)and miR-497(OR=0.839,95%CI:0.750~0.938)were protective factors for T2DM with MVD(all P<0.05).Conclusion The serum miR-103a and miR-497 were low in patients with T2DM complicated with MVD,which may be potential markers for the diagnosis of T2DM complicated with MVD.

杨晓玲;安敏;李玥;孙玮;马亮

唐山职业技术学院附属医院内分泌科,河北唐山 063006

临床医学

2型糖尿病微血管病变微小核糖核酸-103a微小核糖核酸-497

type 2 diabetes mellitusmicro vascular diseasemicro RNA-103amicro RNA-497

《现代检验医学杂志》 2024 (003)

42-47 / 6

2022年度河北省医学科学研究课题计划(NO.20220219):糖尿病患者肠道菌群与微血管功能的改变及药物治疗.

10.3969/j.issn.1671-7414.2024.03.007

评论